Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Org Chem ; 89(10): 7286-7294, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38696309

ABSTRACT

Here we report a carbene-catalyzed enantio- and diastereoselective [4+2] cycloaddition reaction of cyclobutenones with isatins for the quick and efficient synthesis of spirocyclic δ-lactones bearing a chiral chlorine. A broad range of substrates with various substitution patterns proceed smoothly in this reaction, with the spirooxindole δ-lactone products afforded in generally good to excellent yields and optical purities under mild reaction conditions.

2.
Biomed Pharmacother ; 161: 114532, 2023 May.
Article in English | MEDLINE | ID: mdl-37002568

ABSTRACT

The incidence of hyperuricemia and gout has been increasing year by year, and it is showing a younger trend. However, the first-line drugs currently used for hyperuricemia and gouty arthritis have serious side effects that limit their clinical application. Amomum villosum Lour. has been widely used in China for thousands of years as a traditional medical and edible plant, and previous screening showed that the ethanol extract of Amomum villosum Lour. could effectively inhibit the activity of xanthine oxidase. Based on this discovery, this paper had achieved in-depth mechanism research. The results showed that the ethanol extract of Amomum villosum Lour. could treat hyperuricemia by reducing the production of uric acid via inhibition of xanthine oxidase and increasing the excretion of uric acid via regulation of urate transporters. Meanwhile, the extract also showed a certain protective effect on hepatic and renal damage caused by hyperuricemia. With the formation of extensive uric acid, gouty arthritis will be induced by the deposition of monosodium urate in the joint. The extract could also relieve the inflammation by reducing the expression of inflammatory cytokines. In conclusion, the extract deserves focused research and development as a potential medicine, health care product or supplemented food for the prevention and treatment of hyperuricemia and gouty arthritis.


Subject(s)
Arthritis, Gouty , Hyperuricemia , Humans , Uric Acid/metabolism , Ethanol/adverse effects , Xanthine Oxidase/metabolism , Plant Extracts/adverse effects , Hyperuricemia/metabolism , Arthritis, Gouty/chemically induced , Arthritis, Gouty/drug therapy
3.
J Org Chem ; 86(13): 8620-8629, 2021 07 02.
Article in English | MEDLINE | ID: mdl-34097828

ABSTRACT

An efficient aerobic iron-catalyzed annulation of unsaturated carboxylic acids with disulfides has been developed. This procedure proceeds using FeCl3 as the catalyst and KI as an iodine source under an air atmosphere, which provides practical access to a wide range of substituted γ-lactone derivatives. The disclosed method is quite simple, highly atom-economic, environmentally friendly, and tolerates a broad substrate scope.


Subject(s)
Iron , Lactones , Carboxylic Acids , Catalysis , Disulfides
4.
Eur J Med Chem ; 204: 112637, 2020 Oct 15.
Article in English | MEDLINE | ID: mdl-32717477

ABSTRACT

A series of novel substituted triazines bearing a benzimidazole scaffold were designed and synthesized based on the structures of known anti-cancer agents, namely gedatolisib and alpelisib. All the target compounds were screened for inhibitory activity against PI3Kα and mTOR kinases. Notably, most analogs exhibited IC50 in the nanomolar range. Investigation of the isozyme selectivity indicated that the compounds exhibited remarkable inhibitory activity against PI3Kδ, especially compound 19f showed an IC50 value of 2.3 nM for PI3Kδ and moderate δ-isozyme selectivity over other class I PI3K isoforms and mTOR (with IC50 values of 14.6, 34.0, 849.0 and 15.4 nM for PI3Kα, ß, γ and mTOR, respectively). An in vitro MTT assay was conducted to assess the antiproliferative and cytotoxic effects of the prepared analogs. It was revealed that the compounds displayed significant inhibitory activities against the HCT116 human colon cancer cell line. Compound 19i showed 4.7-fold higher potency than the positive control gedatolisib (0.3 vs. 1.4 µM, IC50 values). Phosphoblot studies demonstrated that 19c and 19i could significantly suppress the PI3K/Akt/mTOR signaling pathway at 10 µM. Moreover, analogs 19b, 19c and 19i displayed better stability in artificial gastric fluids than gedatolisib, while 19i was indicated not very stable in rat liver microsomes, and may occur phase I metabolic transformations.


Subject(s)
Drug Design , Phosphatidylinositol 3-Kinases/drug effects , Phosphoinositide-3 Kinase Inhibitors/chemistry , Phosphoinositide-3 Kinase Inhibitors/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors , Triazines/chemistry , Triazines/pharmacology , Cell Proliferation/drug effects , HCT116 Cells , Humans , Inhibitory Concentration 50 , Molecular Docking Simulation , Phosphoinositide-3 Kinase Inhibitors/chemical synthesis , Triazines/chemical synthesis
5.
Bioorg Med Chem Lett ; 29(19): 126608, 2019 10 01.
Article in English | MEDLINE | ID: mdl-31444086

ABSTRACT

A series of hybrid molecules of scutellarein and tertramethylpyrazine's active metabolites have been synthesized. Compared to the original compound, these prepared compounds exhibited higher water solubility, more appropriate logP and better stability. Importantly, compounds 11b, 11d and 11e showed improved neuroprotective activity against the H2O2-induced cell death in PC12 cells, and better antithrombosis activity. The optimized compound 11b was further evaluated by cerebral ischemia/ reperfusion in the middle cerebral artery occlusion (MCAO) model, the results showed that the compound could significantly reduce the infarct area and decrease the neuronal cell damage in CA1 pyramidal neurons. Overall, we demonstrated that the twin drug strategy could be applied in the development of agents for the treatment of ischemic stroke.


Subject(s)
Apigenin/chemistry , Brain Ischemia/drug therapy , Infarction, Middle Cerebral Artery/complications , Neuroprotective Agents/pharmacology , Pyrazines/chemistry , Reperfusion Injury/drug therapy , Stroke/drug therapy , Animals , Brain Ischemia/etiology , Brain Ischemia/pathology , Disease Models, Animal , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/chemistry , PC12 Cells , Rats , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Stroke/etiology , Stroke/pathology
6.
J Org Chem ; 84(12): 8168-8176, 2019 06 21.
Article in English | MEDLINE | ID: mdl-31192597

ABSTRACT

An organocatalytic asymmetric α-sulfenylation of 2-substituted indolin-3-ones with N-(alkylthio or arylthio)succinimides has been developed for the first time using Cinchona-derived squaramide as the catalyst. Various chiral 2,2-disubstituted indole-3-ones with S- and N-containing heteroquaternary carbon stereocenters were obtained with up to 98% yield and 99% ee.

7.
J Org Chem ; 84(4): 2316-2324, 2019 02 15.
Article in English | MEDLINE | ID: mdl-30642180

ABSTRACT

Base-catalyzed efficient hydroxylation of isoquinoline-1,3(2 H,4 H)-diones with air under transition-metal-free and reductant-free conditions was established. This methodology is essentially mild and compatible with a broad range of substrates, including aryl, heteroaryl, and alkyl groups. Also, the product could be simply transformed into a hydroxylated tetrahydroisoquinoline core structure through a reductive process.

SELECTION OF CITATIONS
SEARCH DETAIL
...